[HTML][HTML] Role of anticoagulation in lowering the mortality in hospitalized covid-19 patients: Meta-analysis of available literature
Objectives: To reducing the risk of venous thromboembolic (VTE) events and subsequent
mortality in covid-19 patients is still a matter of research. This systematic review and meta …
mortality in covid-19 patients is still a matter of research. This systematic review and meta …
[HTML][HTML] Femoral nerve palsy as a complication due to COVID-19 coagulopathy and iliopsoas muscle hematoma–case report
S Tutak, P Bartosz, B Burda, P Sztwiertnia… - BMC Musculoskeletal …, 2023 - Springer
Abstract Background COVID-19 (Coronavirus disease 2019) pandemic is the main medical
problem around the world from the end of 2019. We found until now many symptoms of this …
problem around the world from the end of 2019. We found until now many symptoms of this …
[HTML][HTML] Does High-Dose Thromboprophylaxis Improve Outcomes in COVID-19 Patients? A Meta-analysis of Comparative Studies
Background Thromboembolism remains a detrimental complication of novel coronavirus
disease (COVID-19) despite the use of prophylactic doses of anticoagulation Objectives This …
disease (COVID-19) despite the use of prophylactic doses of anticoagulation Objectives This …
Bleeding and thrombosis outcomes in hospitalised COVID‑19 patients on low-molecular-weight heparin and antiplatelet therapy
VPF Lorente, R Van Rensburg, MS Moolla… - South African Medical …, 2022 - ajol.info
Background. An increased incidence of thromboembolic events in hospitalised COVID‑19
patients has been demonstrated despite the use of low-molecular-weight heparin (LMWH) …
patients has been demonstrated despite the use of low-molecular-weight heparin (LMWH) …
[PDF][PDF] Retroperitoneal hematoma in COVID-19 patients-case series.
W Elikowski, N Fertala, M Zawodna-Marszalek… - Pol Merkur …, 2022 - researchgate.net
Case reports. The authors describe 5 cases (3 of those aged more than 80 years) with giant
RPHs and with moderate/severe COVID-19 pneumonia, treated before RPH diagnosis with …
RPHs and with moderate/severe COVID-19 pneumonia, treated before RPH diagnosis with …
Role of anticoagulation in lowering the mortality in hospitalized covid-19 patients: Meta-analysis of available literature.
K Rashid, T Rajab, A Rajab, AH Adnan… - Saudi Medical …, 2022 - europepmc.org
Objectives To reducing the risk of venous thromboembolic (VTE) events and subsequent
mortality in covid-19 patients is still a matter of research. This systematic review and meta …
mortality in covid-19 patients is still a matter of research. This systematic review and meta …
Thrombotic Events and Anticoagulation-Related Bleeding Complications in Critically Ill Patients with Coronavirus Disease 2019
Background: Thrombosis (T) is common in coronavirus disease 2019 (COVID-19) patients,
and d-dimer concentrations correlate with outcomes. Controversy exists with regards to …
and d-dimer concentrations correlate with outcomes. Controversy exists with regards to …
[HTML][HTML] The optimal anticoagulation strategy for COVID-19, prophylactic or therapeutic?: a meta-analysis, trial sequential analysis, and meta-regression of more than …
M Guo, Q Han, J Xing, F Xu, J Wang, C Li… - … and Critical Care …, 2022 - journals.lww.com
Background Anticoagulants are promising regimens for treating coronavirus disease 2019
(COVID-19). However, whether prophylactic or intermediate-to-therapeutic dosage is …
(COVID-19). However, whether prophylactic or intermediate-to-therapeutic dosage is …
[PDF][PDF] Colchicine in Patients With Chronic Coronary Disease
D Kaiser, CD Jackson - The New England journal of medicine, 2021 - gebhardlab.com
To the Editor: In their report on a trial of lowdose colchicine (LoDoCo2) in patients with
chronic coronary disease, Nidorf et al.(Nov. 5 issue) 1 found that those who received …
chronic coronary disease, Nidorf et al.(Nov. 5 issue) 1 found that those who received …
Comparison of standard prophylactic and preemptive therapeutic low molecular weight heparin treatments in hospitalized patients with COVID-19.
N IY, KC AR - Bratislava Medical Journal/Bratislavske …, 2021 - search.ebscohost.com
INTRODUCTION: Anticoagulant treatment approach in patients with COVID-19 is not well
studied and not standardized. We aimed to compare the effects of standard prophylactic and …
studied and not standardized. We aimed to compare the effects of standard prophylactic and …